EXPAREL
Acute Post-Surgical Pain (Pediatric 0 to <6 years)
Phase 3Active
Key Facts
Indication
Acute Post-Surgical Pain (Pediatric 0 to <6 years)
Phase
Phase 3
Status
Active
Company
About Pacira Biosciences
Pacira BioSciences is a mission-driven company dedicated to transforming pain management through innovative, non-opioid therapeutic solutions. Its commercial success is anchored by EXPAREL®, a sustained-release local analgesic, and the iovera° cryoneurolysis system, which together address critical needs in postsurgical and musculoskeletal pain. The company's strategy combines aggressive commercial execution, pipeline expansion into high-value chronic pain indications like osteoarthritis via gene therapy (PCRX-201), and robust advocacy to shape healthcare policy and expand access to non-opioid alternatives.
View full company profile